Open access · OA
via Europe PMC
Health Benefits and Molecular Mechanisms of Urolithin A: From a Gut Microbiota-Derived Metabolite to Translational Applications.
Food science & nutrition · 2026
Dysbiosis
Mitochondrial dysfunction
Chronic inflammation
Disabled macroautophagy
Exercise
Partial reprogramming (OSK)
Cell culture / in vitro
Human
Randomized controlled trial
In vitro
Review
Abstract
Urolithin A (UA) is an important bioactive metabolite generated by the gut microbiota from ellagic acid and ellagitannins. In recent years, it has attracted widespread attention because of its potential value in aging intervention and the prevention and treatment of multisystem diseases. This review systematically summarizes the molecular mechanisms of UA, its effects in disease intervention, and progress in human clinical studies. Existing studies have shown that, with mitochondrial quality control as the core, UA exerts multi-target biological effects through the synergistic regulation of pathways related to inflammatory responses, oxidative stress, mitophagy, and programmed cell death. Findings from in vitro mechanistic studies and animal models suggest that UA may influence pathological processes relevant to degenerative musculoskeletal diseases, cardiovascular diseases, neurological disorders, and cancers, whereas current human clinical evidence remains preliminary and is mainly concentrated in muscle function, exercise-related outcomes, selected metabolic biomarkers, and short- to medium-term safety and tolerability. In addition, this review discusses the bioavailability of UA and its relationship with individual gut microbiota metabolic phenotypes. Future research should focus on high-quality, long-term randomized controlled trials with extended follow-up to promote the application of UA in precision nutrition and its clinical translation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/fsn3.72167
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Z, Y., C, G., Z, D., & X., X. (2026). Health Benefits and Molecular Mechanisms of Urolithin A: From a Gut Microbiota-Derived Metabolite to Translational Applications. <em>Food science & nutrition</em>. https://doi.org/10.1002/fsn3.72167
Vancouver
Z Y, C G, Z D, X. X. Health Benefits and Molecular Mechanisms of Urolithin A: From a Gut Microbiota-Derived Metabolite to Translational Applications. Food science & nutrition. 2026. doi:10.1002/fsn3.72167.
BibTeX
@article{yang2026Health,
title = {Health Benefits and Molecular Mechanisms of Urolithin A: From a Gut Microbiota-Derived Metabolite to Translational Applications.},
author = {Yang Z and Guo C and Deng Z and Xue X.},
journal = {Food science & nutrition},
year = {2026},
doi = {10.1002/fsn3.72167},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Food Science & Nutrition 2026
Open access · CC-BY
Health Benefits and Molecular Mechanisms of Urolithin A: From a Gut Microbiota‐Derived Metabolite to Translational Applications
Frontiers in Nutrition 2026
Open access · CC-BY
Potential impact of urolithin A on pathways relevant to sleep health: a mini review
Cardiovascular Research 2023
Open access · OA
Caloric restriction for the immunometabolic control of human health
Preprints.org 2026
Preprint · CC-BY
Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions
2026
Preprint
Current Status of Senolytics and Senomorphics: Mechanistic Insights, Clinical Progress, and Future Directions
Frontiers in endocrinology 2026
Open access · OA